404 related articles for article (PubMed ID: 11675958)
1. Clinical trial of arotinolol in the treatment of hypertension: dippers vs. non-dippers.
Wu H; Zhang Y; Huang J; Zhang Y; Liu G; Sun N; Yu Z; Zhou Y
Hypertens Res; 2001 Sep; 24(5):605-10. PubMed ID: 11675958
[TBL] [Abstract][Full Text] [Related]
2. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the activity of the autonomic nervous system in "dipper" and "non dipper" essential hypertensives. Gender differences].
Ragot S; Herpin D; Siché JP; Poncelet P; Mallion JM
Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1115-9. PubMed ID: 10486676
[TBL] [Abstract][Full Text] [Related]
6. Effects of alpha,beta-blocker, arotinolol chloride, on 24-h blood pressure--difference between elderly and younger hypertensive patients.
Kuwajima I; Suzuki Y; Otsuka K; Kawamura H; Kuramoto K
J Clin Pharm Ther; 1993 Aug; 18(4):275-80. PubMed ID: 7693739
[TBL] [Abstract][Full Text] [Related]
7. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
8. The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives.
Inanc T; Kaya MG; Yarlioglues M; Ardic I; Ozdogru I; Dogan A; Kalay N; Gunturk E; Gunebakmaz O; Gul I; Topsakal R
Blood Press; 2010 Apr; 19(2):81-5. PubMed ID: 20367545
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
Kereiakes DJ; Neutel J
Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
[TBL] [Abstract][Full Text] [Related]
10. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
11. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin : results from the HALT study.
Kario K; Schwartz JE; Pickering TG
Hypertension; 2000 Mar; 35(3):787-94. PubMed ID: 10720596
[TBL] [Abstract][Full Text] [Related]
12. The circadian rhythms of blood pressure and heart rate in the hypertensive subjects: dippers and non-dippers.
Seo WS; Oh HS
Yonsei Med J; 2002 Jun; 43(3):320-8. PubMed ID: 12089739
[TBL] [Abstract][Full Text] [Related]
13. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.
White WB; Mehrotra DV; Black HR; Fakouhi TD
Am J Cardiol; 1997 Aug; 80(4):469-74. PubMed ID: 9285660
[TBL] [Abstract][Full Text] [Related]
14. Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences?
Ragot S; Herpin D; Siché JP; Ingrand P; Mallion JM
J Hypertens; 1999 Dec; 17(12 Pt 2):1805-11. PubMed ID: 10703872
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory Arterial Stiffness Index (AASI) is Unable to Estimate Arterial Stiffness of Hypertensive Subjects: Role of Nocturnal Dipping of Blood Pressure.
Di Raimondo D; Casuccio A; Di Liberti R; Musiari G; Zappulla V; D'Angelo A; Pinto A
Curr Hypertens Rev; 2017; 13(2):121-131. PubMed ID: 28637401
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation.
Omboni S; Parati G; Palatini P; Vanasia A; Muiesan ML; Cuspidi C; Mancia G
J Hypertens; 1998 Jun; 16(6):733-8. PubMed ID: 9663912
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers shorten the periodicity of ultradian variation in blood pressure in patients with essential hypertension.
Kawamura H; Mitsubayashi H; Saito T; Kanmatsuse K; Saito N
Hypertens Res; 1998 Sep; 21(3):179-86. PubMed ID: 9786602
[TBL] [Abstract][Full Text] [Related]
18. Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.
Chilton R; Tikkanen I; Hehnke U; Woerle HJ; Johansen OE
Diabetes Obes Metab; 2017 Nov; 19(11):1620-1624. PubMed ID: 28387058
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure.
Kario K; Shimada K
Am J Hypertens; 1997 Mar; 10(3):261-8. PubMed ID: 9056682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
